Cytologics launches cell processing and isolation services to support research

Cytologics, a global provider of human biological samples to support biomarker discovery and diagnostics development, today announced the launch of immune cell processing and isolation services to help research institutions with reproducible results. and reduced product variability. According to reports, researchers often face many challenges that compromise the accuracy and quality of their studies.

Biomedical researchers have long been concerned about access to sufficient quantities of human blood and immune cells, the low variability of cell populations from batch to batch, and the difficulty in isolating specific cell types. from a heterogeneous mixture. To meet these needs, Cytologics is launching its services to provide high-quality, ethically-sourced biological samples, using state-of-the-art technologies and highly trained personnel.

Key features of Cytologics Cellular Treatment and Isolation Services include:

  • Aseptic handling of cells to minimize the risk of contamination
  • Separation and isolation of cells using various technologies
  • Robust quality assurance and control protocols for accuracy and reproducibility of results
  • Expert technical support to help researchers with study design, data interpretation, and troubleshooting

Led by a team of immunologists and other experts, Cytologics has a rich history in the characterization of human biological material. Speaking at the launch, a company spokesperson said: “We understand the complexities of isolating human cells and delivering results with consistently high precision.

“As such, our team uses flow cytometry, high-resolution HLA typing and advanced cell isolation technologies to meet the complex research requirements of academic institutions and biopharmaceutical companies. We provide services ranging from PBMC isolation to DNA extraction with an emphasis on quality and speed of execution.

As part of Cytologics’ high-quality, high-volume cell supply capabilities, the company provides PBMCs, CD19+ B cells, NK cells, cytotoxic T cells, CD3+ T cells, and cell pellets. The company also accepts custom orders to meet customer needs. All blood products are collected from FDA-registered collection centers, which means the products are sourced under strict quality and regulatory standards.

Cytologics also offers consulting services, which include:

  • HLA interpretation and analysis
  • Workflow optimization to reduce product variability, cost and development schedule

Beyond these provisions, the Cytologics Bioreserve Service helps researchers manage and preserve their cell sample collections, which are strictly monitored around the clock for humidity and temperature. To ensure optimal conservation, the biodeposit is equipped with an emergency power source to protect the samples from power cuts.

Deliveries are reliable, efficient and on time. Strict temperature monitoring and a controlled transport system ensure that fresh and frozen samples arrive at researchers in perfect condition. The company offers several courier options to ensure that customer-specific delivery requirements are met.

About cytology

Cytologics Inc. is a biotechnology company specializing in providing innovative cell culture products and services for diagnostics, cell therapy and drug development. Founded in 2018 with locations coast to coast, the company aims to improve the quality and speed of testing and reduce the cost and time spent on research. All cell processing and isolation procedures are performed in a highly controlled environment using safe and reliable technologies.

Media Contact
Company Name: Cytological
Contact person: Media Relations
E-mail: Send an email
Call: +1 866 298 6077
Country: United States

Comments are closed.